14.000
+0,00%
2026-10-19
Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +28.3% | +41.7% | 3 / 3 | -36.6% | +11.06 pp | +18.77 pp | +8.6% | 0.39 | 12.68 | 217 | −36,6% | 78,1 | +32,5% | 12.68 | 23.87 | −46,9% |
| Pts | 4 | 8 | 12 | 0 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 14.000 (close price on 2026-10-19)EPS (TTM): 1.104
Financial charts
1.Revenue & growth
VND bn217Q2/26
1.Revenue & growth
VND bn217Q2/26
2.Profit & growth
VND bn67,0Q2/26
3.Profit mix (Penman)
VND bn178Q2/26
4.Margins & cost structure
%18.9%Q2/26
5.Returns & cash cycle
% · days2.7%Q2/26
6.Earnings quality & cash
VND bn292Q2/26
7.Asset structure
VND bn2.674Q2/26
8.Funding & debt health
VND bn · times2.674Q2/26
9.Revenue backlog
VND bn103Q2/26
10.Valuation
times · %12,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %528Q2/26
Adjusted EPS growth, latest quarter
28.3%
Average adjusted EPS growth, 3 quarters
41.7%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26